DOW vs PROF · P/E 74, rev $42.96B vs rev $10.7M
Dow Inc (DOW) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. PROF currently screens at market cap $238.7M.
Not investment advice. Open the DOW and PROF stock pages for the full models.
Not investment advice.